Recent work in cancer cell lines and animal models has demonstrated that lycopene can reduce the transcription of steroid-related genes, insulin-like growth factor-1 expression, and inflammatory signals, suggesting that these pathways may account, in part, for the inverse association between lycopene and the risk of some cancers [24, 25]. The gene discussed is IGF1; the disease is cancer.